Welcome to the GoodCell Newsroom for the latest industry news and analysis, expert insights into the field of cellular therapies and personal biobanking from our founders and scientific advisory board, updates about our offerings, plus a little bit about working at GoodCell.
How genes might predict the risk for severe COVID-19
Read More
Turning Your Genetics into Action​
GoodCell is committed to offering a full spectrum of both inherited and accumulated genetic testing to help people gain a comprehensive view of their risk factors.
Read More

Media & Press

Three-stage research program will leverage GoodCell’s Pathogen Susceptibility Testing Platform using NYBC’s moderate-to-severe COVID-19 patient samples to identify patients at increased risk of adverse clinical outcomes.

A new study could help illuminate “who gets the sniffles and who ends up in the ICU,” says genetic testing company GoodCell’s chief medical officer.

Recent Blog Posts